# Behavioral and Pharmacological Reconsolidation Interference in Misophonia

> **NCT05928689** · EARLY_PHASE1 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 141 (actual)

## Conditions studied

- Misophonia

## Interventions

- **DRUG:** Propranolol Hydrochloride tablet
- **BEHAVIORAL:** Reminder
- **BEHAVIORAL:** Counterconditioning
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05928689
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-02
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05928689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05928689, "Behavioral and Pharmacological Reconsolidation Interference in Misophonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05928689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*